Hotchkis & Wiley Capital Management
AZN icon

Hotchkis & Wiley Capital Management’s AstraZeneca AZN Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,689,214
Closed -$219M – 193
2013
Q4 		$219M Sell
3,689,214
-1,223,235
-25% -$66.5M 0.94% 37
2013
Q3 		$255M Sell
4,912,449
-32,293
-0.7% -$1.62M 1.17% 30
2013
Q2 		$234M Buy
+4,944,742
New +$252M 1.17% 30

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Hotchkis & Wiley Capital Management's AZN Position: Q1 2014 in Review

Hotchkis & Wiley Capital Management sold out of AstraZeneca (AZN) in Q1 2014, closing a stake of 3,689,214 shares — an estimated $219M sold.

Hotchkis & Wiley Capital Management first reported a position in AZN in Q2 2013 and held it in 3 quarters. The position peaked at $255M in Q3 2013. 388 funds tracked by Wall St. Rank hold AZN as of Q1 2014.

  • Hotchkis & Wiley Capital Management reported no remaining AstraZeneca position as of Q1 2014 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 3,689,214 AstraZeneca shares in Q1 2014, an estimated $219M.
  • Hotchkis & Wiley Capital Management first reported a position in AstraZeneca in Q2 2013 and held it in 3 quarters.
  • Hotchkis & Wiley Capital Management's AstraZeneca position peaked at $255M in Q3 2013.
  • 388 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2014.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2014, filed 15 May 2014.